Beam Therapeutics Inc (Symbol: BEAM) has initiated trading for new options expiring on March 20, 2024. The stock currently trades at approximately $29.37 per share. Notably, a put contract at the $29.00 strike price has a current bid of $2.95, offering a potential cost basis of $26.05 for investors willing to sell-to-open the contract, presenting a return of 10.17% if it expires worthless, with a 63% chance of that occurring.
On the call side, a contract at the $31.00 strike price bids at $2.50, potentially providing a 14.06% total return if exercised. This contract is about 6% above the current price, with a 45% likelihood of expiring worthless. Current implied volatilities are 112% for the put and 88% for the call.
The trailing twelve-month volatility for Beam is calculated at 75%. Investors tracking these options may find opportunities aligned with their strategies, bolstered by the YieldBoost metrics available through Stock Options Channel.
